Overview

Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis

Status:
Terminated
Trial end date:
2011-01-20
Target enrollment:
Participant gender:
Summary
To evaluate the causal relationship between Rho/Rho kinase overactivity and mechanisms of vascular dysfunction in patients with atherosclerosis.
Phase:
Phase 2
Details
Lead Sponsor:
Brigham and Women's Hospital
Collaborator:
Doris Duke Charitable Foundation
Treatments:
Fasudil